Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients

Abstract

Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome in hypertensive subjects and was independently associated with hypertension after adjustment for age, gender and metabolic risk factors.